Combination adjuvants: the next generation of adjuvants?
about
Antibiotic alternatives: the substitution of antibiotics in animal husbandry?Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresolSchistosome Vaccine Adjuvants in Preclinical and Clinical Research.Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strainsAssessment of the efficacy of two novel DNA vaccine formulations against highly pathogenic Porcine Reproductive and Respiratory Syndrome Virus.The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications.Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines.Salmonella vaccines in poultry: past, present and future.Combination of adjuvants: the future of vaccine design.The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.The path of malaria vaccine development: challenges and perspectives.Vaccine adjuvant uses of poly-IC and derivatives.A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects.TLR Agonists as Adjuvants for Cancer Vaccines.Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity.
P2860
Q27027984-AE95810F-3CD0-4AFF-8B71-73AC5CA6EE69Q34349745-A5BAD11D-2C54-4E1C-9D4B-E864D10291D5Q35539051-96518547-0C42-4A60-A9D6-5BD73A710B2FQ35826651-4B06756D-618F-4DB9-A7A0-D7CCC2F8C9AAQ36503451-EC723D1F-AB8C-4E33-821A-1D5EDAC19FAFQ36517179-9B905A90-71B4-42E9-8E80-23ACEE95DF85Q36605148-05DF0C7A-6F01-406F-8693-8ADCA61D0ACEQ37623519-451CA0BE-4BFB-4653-AFAD-9D83EBC7DD88Q37956385-7E5CE9E9-6725-452A-9C7E-1A1374BFCB00Q37965727-4867E210-A957-40CD-9DE3-BB26A2C19D6CQ38032881-CE05A49C-8413-484F-8C20-FCA739BF4201Q38068955-E6306992-3999-44CF-A922-58B6ABEB2209Q38124060-A6D29918-5F99-4DAD-8C65-29386D60D733Q38124064-9CEF3E6B-9E5A-421D-B664-770E11384173Q38196455-6B470974-C962-44D8-B5B5-69F4F4825CBEQ38259510-8208D0A3-6D50-4E24-9184-918760DC0D1BQ38926456-3D6F8B2E-79BC-4E74-B856-7A8DAD20D254Q40375946-24878001-0BA4-4C6A-8C6D-8B4C4C751542Q41997055-96D20FB3-1625-4FDC-B393-2DBE009B4FB8Q47110427-0C5AE38D-8323-4267-A864-5E74DD19AB30
P2860
Combination adjuvants: the next generation of adjuvants?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combination adjuvants: the next generation of adjuvants?
@en
Combination adjuvants: the next generation of adjuvants?
@nl
type
label
Combination adjuvants: the next generation of adjuvants?
@en
Combination adjuvants: the next generation of adjuvants?
@nl
prefLabel
Combination adjuvants: the next generation of adjuvants?
@en
Combination adjuvants: the next generation of adjuvants?
@nl
P2093
P2860
P356
P1476
Combination adjuvants: the next generation of adjuvants?
@en
P2093
Andrew Potter
Gael Auray
George Mutwiri
Lorne A Babiuk
Nelson Eng
Srinivas Garlapati
Sylvia van Drunen Littel-van den Hurk
Volker Gerdts
P2860
P304
P356
10.1586/ERV.10.154
P577
2011-01-01T00:00:00Z